Clinical Trials in Atlanta

Showing 11361-11380 of 19,805 trials

Phase I Trial of Measles Vectored Chikungungya Vaccine

NCT03028441

This study is a randomized, double-blinded, Phase 1, placebo- controlled, and dose comparison trial to evaluate the safety, immunogenicity and schedule of MV-CHIK. Two dosage levels and 3 immunization schedules will be evaluated. This study will enroll up to 180 healthy subjects aged 18 to 45 years.Study duration is approximately 22 months. Subject participation duration is approximately 8-13 months. The primary objectives are to evaluate the safety and tolerability of 5 x 10\^4 TCID50 and 5 x 10\^5 TCID50 MV-CHIK and placebo following two consecutive intramuscular injections and to assess the CHIKV serum plaque reduction neutralization test (PRNT50) antibody responses to 5 x 10\^4 TCID50, 5 x 10\^5 TCID50 of MV-CHIK or placebo on day 29 following the first dose.

Chikungunya Virus Infection

National Institute of Allergy and Infectious Diseases (NIAID)180 participantsStarted May 2017

Atlanta, Georgia, United States • Iowa City, Iowa, United States • Houston, Texas, United States

COMPLETED< 1 mile

Clinical Evaluation of PROMIS in CKD

NCT03842293

The purpose of this study is to evaluate the clinical validity of a set of PROMIS pediatric person-reported outcome measures in patients with chronic kidney disease. The evaluation includes longitudinal assessments of how measures change in association with clinical changes.

Chronic Kidney Diseases

Children's Hospital of Philadelphia213 participantsStarted Jun 2017

Birmingham, Alabama, United States • Los Angeles, California, United States • Atlanta, Georgia, United States +13 more locations

Phase I Trial of Measles Vectored Chikungungya Vaccine

Clinical Evaluation of PROMIS in CKD

Find Trials by Condition in Atlanta

Efficacy, Safety and Tolerability of PF-06649751 in Parkinson's Disease Patients at Early Stage of the Disease

Safety and Tolerability Study of Flexible Dosing of Brexpiprazole in the Treatment of Subjects With Agitation Associated With Dementia of the Alzheimer's Type

Trial to Evaluate the Safety and Immunogenicity of 3 Lots of 20-valent Pneumococcal Conjugate Vaccine in Pneumococcal Vaccine-Naïve Adults

Avelumab in Third-Line Gastric Cancer (JAVELIN Gastric 300)

A Study to Evaluate the Effect of Precision Spectra™ Programming Features and Lead Options on Patient Outcomes

A Multinational, Open-Label, Non-Controlled Trial on Safety, Efficacy and Pharmacokinetics of NNC 0129-0000-1003 in Previously Treated Paediatric Patients With Severe Haemophilia A

A Survival Study for Women With Advanced Lung Cancer Who Have Not Previously Received Chemotherapy.

Multiple Areas of Pain (MAP)

Phase 2 Trial of Enzastaurin in Prostate Cancer in Participants Who Have Had Hormonal and Chemotherapy

An Open-label Extension Study To Evaluate Safety Of PF-06252616 In Boys With Duchenne Muscular Dystrophy

Clinical Safety Study of the Progesterone Vaginal Ring in Women Undergoing Assisted Reproductive Technology Procedures

Safety, Tolerability and Pharmacokinetics of MRG-106 in Patients With Mycosis Fungoides (MF), CLL, DLBCL or ATLL

Myelodysplastic Syndromes (MDS) Event Free Survival With Iron Chelation Therapy Study

Assessment of the Ability of Subjects With Acromegaly or Their Partners to Administer Somatuline Autogel

Interdisciplinary Case-Control Study of Non-Hodgkin's Lymphoma

Study of Ataluren for Previously Treated Participants With Nonsense Mutation Duchenne/Becker Muscular Dystrophy (nmDBMD) in Europe, Israel, Australia, and Canada

Safety and Tolerability Study of Cerdulatinib Gel, 0.37% in Adults With Vitiligo

A Study of De-immunized DI-Leu16-IL2 Administered Subcutaneously in Participants With B-cell NHL